Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Polymers (Basel) ; 13(10)2021 May 13.
Article in English | MEDLINE | ID: mdl-34068343

ABSTRACT

Several models of bioartificial human urothelial mucosa (UM) have been described recently. In this study, we generated novel tubularized UM substitutes using alternative sources of cells. Nanostructured fibrin-agarose biomaterials containing fibroblasts isolated from the human ureter were used as stroma substitutes. Then, human Wharton jelly mesenchymal stromal cells (HWJSC) were used to generate an epithelial-like layer on top. Three differentiation media were used for 7 and 14 days. Results showed that the biofabrication methods used here succeeded in generating a tubular structure consisting of a stromal substitute with a stratified epithelial-like layer on top, especially using a medium containing epithelial growth and differentiation factors (EM), although differentiation was not complete. At the functional level, UM substitutes were able to synthesize collagen fibers, proteoglycans and glycosaminoglycans, although the levels of control UM were not reached ex vivo. Epithelial differentiation was partially achieved, especially with EM after 14 days of development, with expression of keratins 7, 8, and 13 and pancytokeratin, desmoplakin, tight-junction protein-1, and uroplakin 2, although at lower levels than controls. These results confirm the partial urothelial differentiative potential of HWJSC and suggest that the biofabrication methods explored here were able to generate a potential substitute of the human UM for future clinical use.

2.
Aging Male ; 22(2): 102-108, 2019 Jun.
Article in English | MEDLINE | ID: mdl-29542389

ABSTRACT

In Europe, countries following the traditional Mediterranean Diet (MeDi), particularly Southern European countries, have lower prostate cancer (PCa) incidence and mortality compared to other European regions. In the present study, we investigated the association between the MeDi and the relative risk of PCa and tumor aggressiveness in a Spanish population. Among individual score components, it has been found that subjects with PCa were less likely to consume olive oil as the main culinary fat, vegetables, fruits and fish than those without. However, these differences were not statistically significative. A high intake of fruit, vegetables and cooked tomato sauce Mediterranean style (sofrito) was related to less PCa aggressiveness. Results showed that there are no differences in the score of adherence to the Mediterranean dietary patterns between cases and controls, with mean values of 8.37 ± 1.80 and 8.25 ± 2.48, respectively. However, MeDi was associated with lower PCa agressiveness according to Gleason score. Hence, relations between Mediterranean dietary patterns and PCa are still inconclusive and merit further investigations. Further large-scale studies are required to clarify the effect of MeDi on prostate health, in order to establish the role of this diet in the prevention of PCa.


Subject(s)
Diet, Mediterranean , Neoplasm Invasiveness/prevention & control , Prostatic Neoplasms/prevention & control , Aged , Case-Control Studies , Diet Surveys , Humans , Male , Middle Aged , Prostatic Neoplasms/epidemiology , Protective Factors , Risk Assessment , Spain/epidemiology
3.
Urol Oncol ; 36(6): 312.e17-312.e23, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29650325

ABSTRACT

BACKGROUND: Somatic mutations have been related to the highest incidence of metastatic disease and different treatment responses. The molecular cause of prostate cancer (PC) is still unclear; however, its progression involves alterations in oncogenes and tumor suppressor genes as well as somatic mutations such as the ones in PIK3CA gene. A high percentage of PC is considered sporadic, which means that the damage to the genes occurs by chance after birth (mainly somatic mutations will drive the cancer event). However, little is known about somatic mutations in PC development. MATERIALS AND METHODS: We evaluated prostate biopsies in the main somatic mutations genes (PIK3CA, TP53, EGFR, KIT, KRAS, PTEN, and BRAF) among individuals with PSA values>4ng/ml (n = 125), including affected and unaffected PC subjects. RESULTS: Mutations in KIT gene are related to aggressive PC: TNM stages II to III, Gleason score ≥ 7 and D'Amico risk (P = 0.037, 0.040, and 0.017). However, there are no statistical significant results when more than 3 somatic mutations are presented in the same individual. In relation to environmental factors (smoking, diet, alcohol intake, or workplace exposure) there are no significant differences in the effect of environmental exposure and the somatic mutation presence. The most prevalent mutations among patients with PC are c.1621A>C (rs3822214) in KIT, c.38G>C (rs112445441) in KRAS and c.733G>A (rs28934575) in TP53 genes. KRAS, KIT, and TP53 genes are the most prevalent ones in patients with PC. CONCLUSIONS: Somatic alterations predisposing to chromosomal rearrangements in PC remain largely undefined. We show that KIT, KRAS, and TP53 genes have a higher presence among patients with PC and that mutations in KIT gene are related to an aggressive PC. However, we did not find any environmental effect in somatic mutations among PC individuals.


Subject(s)
Adenocarcinoma/genetics , Biomarkers, Tumor/genetics , Mutation , Prostatic Neoplasms/genetics , Adenocarcinoma/pathology , Aged , Aged, 80 and over , Case-Control Studies , Class I Phosphatidylinositol 3-Kinases/genetics , Cohort Studies , Computer Simulation , Databases, Factual , Follow-Up Studies , Genetic Predisposition to Disease , Humans , Male , Middle Aged , PTEN Phosphohydrolase/genetics , Prognosis , Prostatic Neoplasms/pathology , Tumor Suppressor Protein p53/genetics
4.
Aging Male ; 21(4): 251-260, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29375002

ABSTRACT

OBJECTIVE: The purpose of this review is to examine the evidence on the effects of bioactive constituents of the Mediterranean diet (MeDi) on prostate cancer (PCa) risk. METHODS: The search for articles came from extensive research in the following databases: PubMed, Scopus, and Web of Science. We used the search terms "Mediterranean diet," "lycopene," "vitamin E," "vitamin C," "Selenium," "resveratrol," "prostate cancer," and combinations, such as "lycopene and prostate cancer" or "resveratrol and prostate cancer." RESULTS: Numerous studies investigating the effect of various dietary nutrients on PCa have suggested that selenium is probably the most promising. Several studies reported reduced PCa risk associated with vitamin C and E intake, while other studies reported no association. Lycopene inhibits cell proliferation and inducts apoptosis, thus protecting against cancer. Also, it has been found in various in vivo and in vitro studies that resveratrol, inhibits PCa development. CONCLUSIONS: The high content of bioactive phytochemicals in the MeDi is of particular interest in the prevention of PCa. Further large-scale studies are required to clarify the effect of MeDi bioactive compounds on prostate health, in order to establish the role of this diet in the prevention of PCa.


Subject(s)
Diet, Mediterranean , Phytochemicals/pharmacology , Prostatic Neoplasms/prevention & control , Anticarcinogenic Agents/pharmacology , Ascorbic Acid/administration & dosage , Humans , Lycopene/pharmacology , Male , Risk Factors , Vitamin E/administration & dosage , Vitamins/administration & dosage
5.
Aging Male ; 21(1): 31-39, 2018 Mar.
Article in English | MEDLINE | ID: mdl-28929838

ABSTRACT

There is an increasing evidence for a link between nutrition, lifestyle and prostate cancer (PCa) development and/or progression of disease. The objective of this study was to examine the association between dietary factors and PCa incidence and aggressiveness in a case-control study. After the analysis of the anatomic pathology, subjects were classified in patients with PCa (n = 157) and controls (n = 158). Clinical data including Gleason score, PSA values and biopsy results, were compiled. Frequencies of food consumption and sociodemographic data were also obtained. The results showed that physical activity was significantly higher in control (p < .022). It was also found that some nutritional habits offer a protective effect among studied subjects, like high nuts (p = .041) and fish (p = .041) intakes. Moreover, there was a significant reduction in risk (p = .029) in cases with a higher fruits and vegetables intakes. A decreased risk of aggressive PCa was associated with fruits, vegetables, legumes and fish intakes. However, these relationships were not statistically significant when data were adjusted for covariates. In conclusion, this study found an inverse association between PCa risk and the intake of fruits and vegetables, fish and nuts. The results suggested that a diet with higher intakes of these foods as Mediterranean diet may lower the risk of PCa in the studied population. As dietary factors are modifiable, identifying food groups or dietary patterns that modulate the risk of PCa and its aggressiveness can offer effective and practical strategies for its primary prevention.


Subject(s)
Diet, Healthy , Disease Progression , Feeding Behavior , Prostatic Neoplasms/prevention & control , Case-Control Studies , Exercise , Fruit , Humans , Male , Meat , Nuts , Surveys and Questionnaires , Vegetables
6.
PLoS One ; 12(10): e0185447, 2017.
Article in English | MEDLINE | ID: mdl-28981526

ABSTRACT

Novel biomarkers for prostate cancer (PCa) diagnosis and prognosis are necessary to improve the accuracy of current ones employed in clinic. We performed a retrospective study between the association of several polymorphisms in the main genes involved in the synthesis and metabolism of sex hormones and PCa risk and aggressiveness. A total of 311 Caucasian men (155 controls and 156 patients) were genotyped for 9 SNPs in AR, CYP17A1, LHCGR, ESR1 and ESR2 genes. Diagnostic PSA serum levels, Gleason score, tumor stage, D´Amico risk and data of clinical progression were obtained for patients at the moment of the diagnosis and after 54 months of follow-up. Chi-squared test were used for comparisons between clinical variables groups, logistic regression for clinical variables associations between SNPs; and Kaplan-Meier for the association between SNPs and time to biochemical progression. We found 5 variants (CYP17A1) rs743572, rs6162, rs6163; (LHCGR) rs2293275 and (ESR2) rs1256049 that were statistically significant according to clinical variables (PSA, D´Amico risk and T stage) on a case-case analysis. Moreover, the presence of A and G alleles in rs743572 and rs6162 respectively, increase the risk of higher PSA levels (>10 ng/µl). With respect to D´Amico risk rs743572 (AG-GG), rs6162 (AG-AA) and rs6163 (AC-AA) were associated with an increased risk; and last, AC and AA genotypes for rs6163 were associated with a shorter biochemical recurrence free survival (BRFS) in patients with radical prostatectomy. In multigene analysis, several variants in SNPs rs2293275, rs6152, rs1062577, rs6162, rs6163, rs1256049 and rs1004467 were described to be associated with a more aggressiveness in patients. However, none of the selected SNPs show significant values between patients and controls. In conclusion, this study identified inherited variants in genes CYP17A1, LHCGR and ESR2 related to more aggressiveness and/or a poor progression of the disease. According to this study, new promise PCa biomarkers for clinical management could be included in these previous SNPs.


Subject(s)
Gonadal Steroid Hormones/biosynthesis , Polymorphism, Single Nucleotide , Prostatic Neoplasms/pathology , Case-Control Studies , Humans , Male , Multigene Family , Prostatic Neoplasms/genetics , Prostatic Neoplasms/metabolism , Recurrence
7.
Oncotarget ; 8(41): 70472-70480, 2017 Sep 19.
Article in English | MEDLINE | ID: mdl-29050295

ABSTRACT

Circulating tumor cells (CTCs) have been recently accepted as prognostic markers in metastatic prostate cancer (PCa). However, very few studies have analyzed their role in early-stage PCa. The aim of this research is to study the value of CTCs at the moment of PCa diagnosis and to identify different subpopulations of CTCs. Patients with PSA value > 4 ng/ml and clinical suspicion of PCa were included. Samples were collected immediately before prostatic biopsy. CTCs were isolated by immunomagnetic technique using a multi-CK specific antibody. Molecular expression of EGFR and AR in the tissue was analysed by real-time PCR. Up to eight different SNPs in patients' blood DNA were studied. In a total of 86 patients, the CTC detection rate was 18.6%. The sensitivity, specificity, positive and negative predictive values of CTCs to detect PCa was 14.2%, 78.4%, 31.2% and 57.4%, respectively. Up to 75% of CTC-positive patients were AR-negative. A direct association was found between the expression of AR in the prostatic tissue and the presence of CTCs in blood (p<0.05). We observed an inverse relation between the expression of EGFR in the tissue and the expression of AR in the CTCs. No significant association between SNPs and CTCs was found. The low detection rate of CTCs in early-stage PCa limits their role as a diagnostic marker. Nevertheless, we show that they may hide important prognostic information. Overexpression of AR in the prostate may facilitate cell dissemination.

8.
Urol Oncol ; 34(10): 431.e1-8, 2016 10.
Article in English | MEDLINE | ID: mdl-27318894

ABSTRACT

BACKGROUND: There is contradictory evidence of the effects that environmental factors-dietary habits (ingestion rates of red meat, soy products, fish, etc.) and work environment (exposure to metals, pesticides, several toxic products, etc.)-and KLK3, AR, RNASEL, MSR1, and ELAC2 expression patterns have on prostate cancer (PCa). In our study, we investigated the potential association between KLK3, AR, RNASEL, MSR1, and ELAC2 polymorphisms, expression patterns, exposure to environmental factors, and PCa in a Spanish cohort. Blood and fresh tissue samples were collected from 322 subjects with prostate-specific antigen (PSA)>4ng/ml to determine their genotypes (RNASEL, MSR1, and ELAC2) and assess messenger ribonucleic acid expression levels (by quantitative amplification testing). MAIN FINDINGS: Among clinical parameters, a 63.6% of patients with CC variants in rs11545302 (ELAC2) had PSA>20ng/ml (P = 0.008), and rs486907 (RNASEL), with 52.8% of patients with CT variants with Gleason score>7. Regarding TNM stage, patients with GG variants, rs4792311 (ELAC2) generally had stage 1 tumors. Genetic expression analysis revealed RNASEL (P = 0.007) was underexpressed in PCa tissue, whereas KLK3 (P = 0.041) was overexpressed. As to environmental factors, the intake of dried fruits (P = 0.036) and practice of sports (P = 0.024) revealed an effect in PCa. Moreover, environmental factors were observed to affect gene expression patterns. Thus, RNASEL (P = 0.018) and ELAC2 (P = 0.023) were found to be underexpressed in patients who ate processed foods frequently; MSR1 (P = 0.024) and AR (P = 0.004) were underexpressed in patients who did not practice sports; and KLK3 (P = 0.039; P = 0.046) underexpressed in patients exposed to dust and toxic products. CONCLUSIONS: This is the first study to analyze the correlation between RNASEL, MSR1, and ELAC2 genotypes and messenger ribonucleic acid expression in PCa. RNASEL and KLK3 show different expression patterns in normal vs. tumor tissue, which supports their reported relevance in human cancer. The results obtained confirm that RNASEL plays a crucial role in PCa. Environmental factors such as exercise, exposure to toxic agents, and intake of processed foods are associated with PCa.


Subject(s)
Endoribonucleases/genetics , Environmental Exposure , Gene Expression , Neoplasm Proteins/genetics , Prostatic Neoplasms/genetics , RNA, Messenger/metabolism , Scavenger Receptors, Class A/genetics , Aged , Biomarkers, Tumor/metabolism , Diet , Dust , Fruit , Gene-Environment Interaction , Genotype , Germ-Line Mutation , Hazardous Substances , Humans , Kallikreins/genetics , Male , Middle Aged , Neoplasm Grading , Polymorphism, Single Nucleotide , Prostate-Specific Antigen/blood , Prostate-Specific Antigen/genetics , Prostatic Neoplasms/blood , Prostatic Neoplasms/pathology , Risk Factors , Spain , Sports/physiology , Surveys and Questionnaires
9.
Arch Esp Urol ; 69(4): 155-61, 2016 May.
Article in Spanish | MEDLINE | ID: mdl-27225059

ABSTRACT

OBJECTIVE: To provide an updated epidemiological description of urinary lithiasis in a health area in the Western hemisphere over the past four decades. METHODS: 2704 urinary lithiases analysed in our institution between 1980 and 2015 were retrospectively reviewed. They were analyzed using polarized light microscopy, and in the case this method had questionable results we used X-ray diffraction. The variables collected were the lithiasis chemical composition (oxalates, phosphates, uric acid, infectious, cystine, mixed, other). Regarding the date of the analysis, the series of cases was grouped into four periods (1980-1989, 1990- 1999, 2000-2009, and 2010-2015), and also by sex and age of the patient. RESULTS: The mean age at diagnosis was 48.32 years (49.37 in men vs 46.53 in women, p=0.005). A male predominance was found (58.7%). Throughout the four decades, the involvement of women has progressively diminished compared to men. Of all the lithiases, the most frequent were those composed of oxalates (43.3%), followed by uric acid (16.9%) and infectious types (10.7%). The uric acid and oxalate lithiases were more common in men than in women (67.4% vs. 32.6% and 59.1% vs. 40.9%, respectively, p<0.001), while the lithiasis of infectious origin was more frequent in women than in men (56.3% vs. 43.7%, p<0.001). Throughout the time period, a trend of increasing oxalic lithiases and decreasing uric acid and phosphate lithiases was observed, as well as an increase of infectious lithiases over the past five years. CONCLUSIONS: In our setting, urinary lithiases appear more frequently in males at the end of the fourth decade of life. The most common lithiases are composed of oxalates, and their frequency has increased over time, while uric acid and phosphates lithiases have decreased.


Subject(s)
Urolithiasis/epidemiology , Urolithiasis/urine , Adult , Catchment Area, Health , Female , Humans , Male , Middle Aged , Retrospective Studies , Spain/epidemiology , Time Factors
10.
Arch. esp. urol. (Ed. impr.) ; 69(4): 155-161, mayo 2016. graf, tab
Article in Spanish | IBECS | ID: ibc-151903

ABSTRACT

OBJETIVO: Obtener una descripción actualizada de las características epidemiológicas de las litiasis urinarias de un área sanitaria occidental durante las últimas cuatro décadas. MÉTODOS: Revisamos retrospectivamente 2704 litiasis analizadas en un área sanitaria española entre 1980 y 2015. El análisis se realizó mediante microscopía de luz polarizada, y si dicho método presentaba resultados dudosos se recurrió a la difracción con rayos X. Las variables recogidas fueron: la composición química de las litiasis (oxalatos, fosfatos, ácido úrico, infecciosas, cistina, mixtas, otras), la fecha del análisis agrupada en cuatro periodos (1980-1989, 1990-1999, 2000- 2009, 2010-2015), el sexo y la edad del paciente. RESULTADOS: La edad media al diagnóstico fue de 48,32 años (49,37 en varones vs 46,53 en mujeres, p = 0,005). Se encontró un predominio masculino (58,7%), y a lo largo de las cuatro décadas, la afectación en mujeres disminuyó. Las litiasis más frecuentes fueron las compuestas por oxalatos (43,3%), seguidas de las de ácido úrico (16,9%) y las infecciosas (10,7%). Las litiasis úricas y oxálicas fueron más frecuentes en varones que en mujeres (67,4% vs 32,6% y 59,1% vs 40,9%, respectivamente, p < 0,001); sin embargo, las de origen infeccioso fueron más frecuentes en mujeres que en varones (56,3% vs 43,7%, p < 0,001). Se apreció una tendencia al aumento de las litiasis oxálicas y a la disminución de las úricas y por fosfatos. Además, observamos un incremento de las litiasis infecciosas en los últimos 5 años. CONCLUSIONES: En nuestro medio, las litiasis aparecen con más frecuencia en varones en la cuarta década de la vida. Las más frecuentes son las oxálicas, cuya proporción ha aumentado a lo largo de las últimas décadas, mientras que las de ácido úrico y fosfato han disminuido


OBJECTIVE: To provide an updated epidemiological description of urinary lithiasis in a health area in the Western hemisphere over the past four decades. METHODS: 2704 urinary lithiases analysed in our institution between 1980 and 2015 were retrospectively reviewed. They were analyzed using polarized light microscopy, and in the case this method had questionable results we used X-ray diffraction. The variables collected were the lithiasis chemical composition (oxalates, phosphates, uric acid, infectious, cystine, mixed, other). Regarding the date of the analysis, the series of cases was grouped into four periods (1980-1989, 1990- 1999, 2000-2009, and 2010-2015), and also by sex and age of the patient. RESULTS: The mean age at diagnosis was 48.32 years (49.37 in men vs 46.53 in women, p = 0.005). A male predominance was found (58.7%). Throughout the four decades, the involvement of women has progressively diminished compared to men. Of all the lithiases, the most frequent were those composed of oxalates (43.3%), followed by uric acid (16.9%) and infectious types (10.7%). The uric acid and oxalate lithiases were more common in men than in women (67.4% vs. 32.6% and 59.1% vs. 40.9%, respectively, p p < 0.001), while the lithiasis of infectious origin was more frequent in women than in men (56.3% vs. 43.7%, p < 0.001). Throughout the time period, a trend of increasing oxalic lithiases and decreasing uric acid and phosphate lithiases was observed, as well as an increase of infectious lithiases over the past five years. CONCLUSIONS: In our setting, urinary lithiases appear more frequently in males at the end of the fourth decade of life. The most common lithiases are composed of oxalates, and their frequency has increased over time, while uric acid and phosphates lithiases have decreased


Subject(s)
Humans , Male , Female , Young Adult , Adult , Middle Aged , Aged , Urolithiasis/epidemiology , Urolithiasis/etiology , Urolithiasis/pathology , Lithiasis/classification , Lithiasis/diagnosis , Sex , 50293 , Microscopy, Polarization/instrumentation , Microscopy, Polarization/methods , Microscopy, Polarization , X-Ray Diffraction/instrumentation , X-Ray Diffraction/methods , X-Ray Diffraction , Retrospective Studies , Spain/epidemiology
11.
Curr Drug Targets ; 17(6): 693-701, 2016.
Article in English | MEDLINE | ID: mdl-25751007

ABSTRACT

Circulating Tumor Cells (CTCs) are a valuable prognostic factor in several solid tumors. By understanding the biological characteristics of CTCs we could better understand the biology of metastasis. CTCs usually adopt a dormant state that is believed to be a strategy to survive in extreme conditions. To enter a dormant state, CTCs undergo numerous phenotypic, genetic and functional mutations that significantly affect the efficacy of the therapies used to kill dormant CTCs. Hence, understanding the biological events involved in the dormancy process of CTCs would allow the identification of new therapeutic targets. Some experimental studies or preclinical models have explored these biological events, as well as the molecular factors that contribute to the maintenance of and release from dormancy. However, few studies have assessed the effects of anticancer therapies on dormant cells. This study reviews current the data currently available on cell dormancy mechanisms in prostate cancer, with a special focus on the functional, genetic and phenotypic plasticity of CTCs and their potential implications in the clinical and therapeutic management of prostate cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Neoplastic Cells, Circulating/drug effects , Prostatic Neoplasms/pathology , Antineoplastic Agents/therapeutic use , Epithelial-Mesenchymal Transition/drug effects , Humans , Male , Mutation , Neoplasm Metastasis , Neoplastic Cells, Circulating/pathology , Phenotype , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/genetics
12.
Arch Esp Urol ; 68(9): 722, 2015 Nov.
Article in Spanish | MEDLINE | ID: mdl-26677471

ABSTRACT

We present the case of a 60-year-old male diagnosed with end stage renal disease due to polycystic kidney disease (urinary flow rate between 100-150mL/24h) in the study to enter renal transplantation waiting list. The patient complained of a right inguinoscrotal bulky mass, first noticed several years before. Physical examination suggested an irreducible inguinoscrotal hernia and surgical repair was offered before transplantation.


Subject(s)
Cystocele/diagnostic imaging , Scrotum , Humans , Incidental Findings , Male , Middle Aged , Radiography
13.
Int J Food Sci Nutr ; 66(7): 805-10, 2015.
Article in English | MEDLINE | ID: mdl-26327471

ABSTRACT

The aim of the present study was to determine the association between the socio-demographic, lifestyle factors, and dietary habits with the risk of prostate cancer (PC) in a case-control study of Spanish men. None of the socio-demographic, lifestyle or dietetic variables was found predictors of PC risk. Body mass index was associated with an increased risk for aggressive PC and fruit consumption with lower Gleason scores, thus less aggressive cancers. Nonetheless, after applying Bonferroni correction, these variables were not still associated with PC aggressiveness. More adequately, powered epidemiological studies that measure the effect of lifestyle and dietary intake in PC risk and aggressiveness are warranted to further elucidate the role of these modifiable factors on PC etiology.


Subject(s)
Diet , Feeding Behavior , Life Style , Prostatic Neoplasms/etiology , Aged , Case-Control Studies , Humans , Male , Risk Factors , Spain
14.
Exp Mol Med ; 47: e176, 2015 Aug 07.
Article in English | MEDLINE | ID: mdl-26251261

ABSTRACT

The aim of this study was to analyze the use of 12 single-nucleotide polymorphisms in genes ELAC2, RNASEL and MSR1 as biomarkers for prostate cancer (PCa) detection and progression, as well as perform a genetic classification of high-risk patients. A cohort of 451 men (235 patients and 216 controls) was studied. We calculated means of regression analysis using clinical values (stage, prostate-specific antigen, Gleason score and progression) in patients and controls at the basal stage and after a follow-up of 72 months. Significantly different allele frequencies between patients and controls were observed for rs1904577 and rs918 (MSR1 gene) and for rs17552022 and rs5030739 (ELAC2). We found evidence of increased risk for PCa in rs486907 and rs2127565 in variants AA and CC, respectively. In addition, rs627928 (TT-GT), rs486907 (AG) and rs3747531 (CG-CC) were associated with low tumor aggressiveness. Some had a weak linkage, such as rs1904577 and rs2127565, rs4792311 and rs17552022, and rs1904577 and rs918. Our study provides the proof-of-principle that some of the genetic variants (such as rs486907, rs627928 and rs2127565) in genes RNASEL, MSR1 and ELAC2 can be used as predictors of aggressiveness and progression of PCa. In the future, clinical use of these biomarkers, in combination with current ones, could potentially reduce the rate of unnecessary biopsies and specific treatments.


Subject(s)
Endoribonucleases/genetics , Neoplasm Proteins/genetics , Polymorphism, Single Nucleotide , Prostate/pathology , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/genetics , Scavenger Receptors, Class A/genetics , Aged , Aged, 80 and over , Cohort Studies , Disease Progression , Gene Frequency , Genetic Markers/genetics , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Prognosis , Prostate/metabolism
15.
Urology ; 82(6): 1440-3, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24094655

ABSTRACT

INTRODUCTION: A short right renal vein remains a challenge for renal transplant surgery, especially in the living donor. Our objective was to report on a new technique to solve this problem. TECHNICAL CONSIDERATIONS: We describe our experience with the use of cryopreserved iliac artery grafts for right renal vein extension. Two renal grafts from living donors with a short right renal vein were subjected to an extension with a cryopreserved external iliac artery allograft. There were no perioperative or postoperative complications. There were also no changes in ischemia times. The renal implantation was performed easily and conveniently using our standard technique. For the first and second procedures, at 3 and 3.5 years after surgery, respectively, both vascular grafts maintain good patency, and the renal function of both recipients is optimal. CONCLUSION: Tissue-banked cryopreserved cadaveric vessels can be a useful tool in renal transplant surgery. The use of a cryopreserved iliac artery for renal vein extension is a simple and effective new technique that can be added to the pool of surgical solutions for a short renal vein in living-donor kidney transplantation. To our knowledge, this is the first time that the use of such grafts for this purpose has been described.


Subject(s)
Cryopreservation , Iliac Artery/transplantation , Kidney Transplantation/methods , Renal Veins/surgery , Adult , Allografts , Anastomosis, Surgical , Cold Ischemia , Humans , Living Donors , Middle Aged , Renal Veins/pathology , Vascular Patency
16.
Arch Esp Urol ; 62(6): 461-5, 2009 Jul.
Article in English, Spanish | MEDLINE | ID: mdl-19736375

ABSTRACT

OBJECTIVES: We report the cases of three patients with primary renal lymphoma. Diagnosis and subsequent treatment are discussed. METHODS: The literature on the origin, epidemiology, clinical presentation, diagnosis, treatment and prognosis of primary renal lymphoma was reviewed. RESULTS: The first patient was diagnosed after radical nephrectomy and subsequently was given six cycles of CVP (cyclophosphamide, vincristine, prednisone). The diagnosis of the second patient was established by renal biopsy, and the patient received six cycles of CHOP (cyclophosphamide, adriamycin, vincristine and predisone). The last patient had a lymphoma, secondary to immunosuppression, in a transplanted kidney. In this case transplant nephrectomy sufficed to cure the patient's lymphoma. All patients had B-cell non-Hodgkin lymphoma (an extrarenal origin was ruled out by bone marrow biopsy), and were disease-free 15 months, 7 months, and 6.5 years after diagnosis, respectively. CONCLUSIONS: Primary renal lymphoma is rare. Diagnosis is established by renal biopsy, although it often presents as a mass simulating renal cell cancer and diagnosis is obtained after radical nephrectomy. Treatment consists of chemotherapy (CHOP). associated with rituximab.


Subject(s)
Kidney Neoplasms , Lymphoma, B-Cell , Aged , Female , Humans , Kidney Neoplasms/diagnosis , Kidney Neoplasms/therapy , Lymphoma, B-Cell/diagnosis , Lymphoma, B-Cell/therapy , Male , Middle Aged
17.
Actas Urol Esp ; 33(5): 569-74, 2009 May.
Article in Spanish | MEDLINE | ID: mdl-19658311

ABSTRACT

OBJECTIVE: To assess current management of renal cell carcinoma (RCC) extending into the inferior vena cava (IVC): staging, diagnosis, surgical approach, adjuvant therapy, prognostic factors and survival rate. MATERIALS AND METHODS: Nineteen cases of RCC extending into the IVC undergoing surgical resection from January 1988 to August 2008 were reviewed. TNM staging and Neves-Zincke grading of the tumor were also assessed. Surgical approach depended on thrombus level. RESULTS: With a perioperative mortality rate of 10.5% and a mean follow-up of 22.65 months (range 2-79), 5 patients are still alive, while 11 patients died from the disease, 1 from an unrelated cause, and 2 were lost to follow-up. Patients with metastatic disease received adjuvant treatment with immunotherapy or kinase inhibitors. Mean survival was 15.1 months. Significant differences were found in 3- and 5-year survival rates in patients staged as N0M0 as compared to all other stages (N+M0, N0M+, N+M+). No differences were found depending on thrombus level. CONCLUSIONS: RCC with thrombus in the IVC is a tumor with a high mortality rate. Surgery continues to be the best option, and requires adequate preoperative evaluation and the support of an experienced and well trained multidisciplinary team. Survival depends on disease extension.


Subject(s)
Carcinoma, Renal Cell/secondary , Carcinoma, Renal Cell/therapy , Kidney Neoplasms/pathology , Neoplastic Cells, Circulating , Vena Cava, Inferior , Adult , Aged , Carcinoma, Renal Cell/mortality , Female , Humans , Male , Middle Aged , Survival Rate
18.
Arch. esp. urol. (Ed. impr.) ; 62(6): 461-465, jul.-ago. 2009. ilus
Article in Spanish | IBECS | ID: ibc-75329

ABSTRACT

OBJETIVOS: Se presentan tres casos clínicos de pacientes con linfoma renal primario, su diagnóstico y posterior tratamiento.MÉTODOS: Se realiza una revisión bibliográfica del origen, epidemiología, características clínicas, diagnóstico, tratamiento y pronóstico de esta enfermedad.RESULTADOS: En nuestro primer caso la paciente es diagnosticada tras una nefrectomía radical y tratada posteriormente con seis ciclos de CVP (ciclofosfamida, vincristina, prednisona). En el segundo paciente el diagnóstico se llevó a cabo mediante biopsia renal, administrándose seis ciclos de CHOP (ciclofosfamida, adriamicina, vincristina y prednisona). El último caso se trata de un linfoma secundario a la inmunosupresión en un riñón trasplantado en la que la realización de una trasplantectomía fue suficiente. Todos los casos fueron linfomas no-Hodgkin de células B descartándose el origen extrarrenal con biopsia de médula ósea, estando libres de enfermedad tras 15, 7 meses y 6.5 años del diagnóstico respectivamente.CONCLUSIONES: El linfoma renal primario es muy raro. El diagnóstico se realiza mediante biopsia renal aunque con frecuencia se presenta como una masa simulando un cáncer renal y es diagnosticado tras nefrectomía radical. El tratamiento consiste en quimioterapia (CHOP) asociada a rituximab(AU)


OBJECTIVES: We report the cases of three patients with primary renal lymphoma. Diagnosis and subsequent treatment are discussed.METHODS: The literature on the origin, epidemiology, clinical presentation, diagnosis, treatment and prognosis of primary renal lymphoma was reviewed.RESULTS: The first patient was diagnosed after radical nephrectomy and subsequently was given six cycles of CVP (cyclophosphamide, vincristine, prednisone). The diagnosis of the second patient was established by renal biopsy, and the patient received six cycles of CHOP (cyclophosphamide, adriamycin, vincristine and prednisone). The last patient had a lymphoma, secondary to immunosuppression, in a transplanted kidney. In this case transplant nephrectomy sufficed to cure the patient’s lymphoma. All patients had B-cell non-Hodgkin lymphoma (an extrarenal origin was ruled out by bone marrow biopsy), and were disease-free 15 months, 7 months, and 6.5 years after diagnosis, respectively.CONCLUSIONS: Primary renal lymphoma is rare. Diagnosis is established by renal biopsy, although it often presents as a mass simulating renal cell cancer and diagnosis is obtained after radical nephrectomy. Treatment consists of chemotherapy (CHOP) associated with rituximab(AU)


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Kidney Neoplasms , Kidney Neoplasms/diagnosis , Kidney Neoplasms/etiology , Kidney Neoplasms/therapy , Kidney Neoplasms/drug therapy , Lymphoma , Biopsy , Nephrectomy , Nephrectomy/methods , Chemotherapy, Cancer, Regional Perfusion , Case Reports
19.
Actas urol. esp ; 33(5): 569-574, mayo 2009. tab, graf, ilus
Article in Spanish | IBECS | ID: ibc-60303

ABSTRACT

Objetivo: Valorar la situación actual en el tratamiento del carcinoma renal con extensión a vena cava inferior (VCI): Clasificación, diagnóstico, abordaje quirúrgico, terapia adyuvante, factores de pronóstico y supervivencia. Materiales y Métodos: Se revisan 19 casos de carcinomas renales con extensión a VCI intervenidos entre enero de 1988 y agosto de 2008. Se valoran la edad, el sexo, lateralidad y función renal de los pacientes. Con respecto al tumor se valoran: estadio según TNM y la clasificación de Neves-Zincke. Se describe el abordaje quirúrgico según el nivel del trombo. Resultados: Con una tasa de mortalidad perioperatoria del 10.5% y una media de seguimiento de 22,65 meses (rango 2-79), sobreviven 5 pacientes; 11 han fallecido por la enfermedad; uno por otra causa y 2 se han perdido. Los pacientes metastásicos han recibido tratamiento adyuvante con Inmunoterapia o inhibidores de las kinasas. La supervivencia media es de 15,1 meses. Existen diferencias significativas a tres y cinco años en la supervivencia de los pacientes estadiados como N0M0 vs resto (N+M0, N0M+, N+M+). No hay diferencias en función del nivel del trombo. Conclusiones: El carcinoma renal con trombo en VCI es un tumor con alta mortalidad. El abordaje quirúrgico del mismo es la opción más valida y precisa una correcta valoración prequirúrgica y el apoyo de un equipo multidisciplinar preparado y con experiencia. La supervivencia depende de la extensión de la enfermedad (AU)


Objective: To assess current management of renal cell carcinoma (RCC) extending into the inferior vena cava (IVC): staging, diagnosis, surgical approach, adjuvant therapy, prognostic factors and survival rate. Materials and Methods: Nineteen cases of RCC extending into the IVC undergoing surgical resection from January 1988to August 2008 were reviewed. TNM staging and Neves-Zincke grading of the tumor were also assessed. Surgical approach depended on thrombus level. Results: With a perioperative mortality rate of 10.5% and a mean follow-up of 22.65 months (range 2-79), 5 patients are still alive, while 11 patients died from the disease, 1 from an unrelated cause, and 2 were lost to follow-up. Patients with metastatic disease received adjuvant treatment with immunotherapy or kinase inhibitors. Mean survival was 15.1 months. Significant differences were found in 3- and 5-year survival rates in patients staged as N0M0 as compared to all other stages (N+M0, N0M+, N+M+). No differences were found depending on thrombus level. Conclusions: RCC with thrombus in the IVC is a tumor with a high mortality rate. Surgery continues to be the best option, and requires adequate preoperative evaluation and the support of an experienced and well trained multidisciplinary team. Survival depends on disease extension (AU)


Subject(s)
Humans , Nephrectomy/methods , Kidney Neoplasms/surgery , Carcinoma, Renal Cell/surgery , Kidney Neoplasms/pathology , Superior Vena Cava Syndrome/complications , Venae Cavae/pathology , Disease-Free Survival
20.
Arch Esp Urol ; 61(5): 631-3, 2008 Jun.
Article in Spanish | MEDLINE | ID: mdl-18709820

ABSTRACT

OBJECTIVE: We report the case of a 61-year-old male with the incidental diagnosis of intrathoracic renal ectopia during the workup study for a possible lung mass. METHODS: We performed a bibliographic review on the incidence, origin, clinical presentation and diagnosis of this type of renal ectopia. RESULTS: Chest x-ray showed a left posterior mediastinum mass. Bronchoscopy was performed showing signs of extrinsic compression with absence of neoplastic cells. CT scan revealed a left intrathoracic ectopic kidney with diaphragmatic hernia. CONCLUSIONS: Intrathoracic renal ectopia is a very unfrequent finding, often asymptomatic, frequently an incidental diagnosis that does not require treatment.


Subject(s)
Kidney/abnormalities , Thorax , Congenital Abnormalities/diagnostic imaging , Humans , Male , Middle Aged , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...